On May 6th, Vertex Pharmaceuticals’ adjusted EPS for the first quarter was $4.06, with analysts expecting $4.29; The expected overall revenue for the year is between $18.5 million and $012 million, compared to the company’s original estimate of $0.18 million to $0.12 million.
Scan code to share